Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells.
A screen for modifiers of cyclin E function in Drosophila melanogaster identifies Cdk2 mutations, revealing the insignificance of putative phosphorylation sites in Cdk2.
Characterizing medical decision-making in sickle cell disease during childhood: Qualitative perspectives of caregivers.
Hospital Procalcitonin Testing and Antibiotic Treatment of Patients Admitted for Chronic Obstructive Pulmonary Disease Exacerbation.
How to Treat High-Risk Myeloma at Diagnosis and Relapse.
See All 9 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
How to Treat High-Risk Myeloma at Diagnosis and Relapse.
Caro J, Al Hadidi S, Usmani S, Yee AJ, Raje N, Davies FE. How to Treat High-Risk Myeloma at Diagnosis and Relapse. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:291-309.
View in:
PubMed
subject areas
Hematopoietic Stem Cell Transplantation
Humans
Multiple Myeloma
Proteasome Inhibitors
Recurrence
Transplantation, Autologous
authors with profiles
Saad Usmani MD